Expanded Access Advocates Seek Reimbursement Mandate, Manufacturer Incentives From Congress

 
• By Sue Sutter
  
A man is building a ladder or growth chart from blocks. Strategy planning business expansion. Climbing the career ladder. Increase in income, organization of processors. Prioritization. Leadership
Measures to further expand access to investigational medicines could find their way into Cures 2.0 legislation. • Source: Shutterstock
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Legislation

More from Pink Sheet